NDC 71872-7187

BRIDION

Sugammadex

BRIDION is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Medical Purchasing Solutions, Llc. The primary component is Sugammadex Sodium.

Product ID71872-7187_9e3eb206-5c36-2c93-e053-2a95a90a9df0
NDC71872-7187
Product TypeHuman Prescription Drug
Proprietary NameBRIDION
Generic NameSugammadex
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-12-15
Marketing CategoryNDA / NDA
Application NumberNDA022225
Labeler NameMedical Purchasing Solutions, LLC
Substance NameSUGAMMADEX SODIUM
Active Ingredient Strength100 mg/mL
Pharm Classesgamma-Cyclodextrins [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71872-7187-1

1 VIAL, SINGLE-DOSE in 1 BAG (71872-7187-1) > 2 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-12-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71872-7187-1 [71872718701]

BRIDION INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA022225
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-16

Drug Details

Active Ingredients

IngredientStrength
SUGAMMADEX SODIUM100 mg/mL

Pharmacological Class

  • gamma-Cyclodextrins [CS]

NDC Crossover Matching brand name "BRIDION" or generic name "Sugammadex"

NDCBrand NameGeneric Name
0006-5423BRIDIONsugammadex
0006-5425BRIDIONsugammadex
71872-7187BRIDIONsugammadex

Trademark Results [BRIDION]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BRIDION
BRIDION
86588109 4979416 Live/Registered
Merck Sharp & Dohme B.V.
2015-04-06
BRIDION
BRIDION
86228696 4978527 Live/Registered
Merck Sharp & Dohme B.V.
2014-03-21
BRIDION
BRIDION
86228692 5223500 Live/Registered
Merck Sharp & Dohme B.V.
2014-03-21
BRIDION
BRIDION
85402383 not registered Dead/Abandoned
MERCK SHARP & DOHME B.V.
2011-08-19
BRIDION
BRIDION
79005765 3055628 Live/Registered
MERCK SHARP & DOHME B.V.
2004-09-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.